Burden of virus-associated liver cancer in the Arab world, 1990-2010

Area of Science:

• Hepatology
• Oncology
• Epidemiology

Background:

• Hepatocellular carcinoma (HCC) is a leading cause of cancer death globally.
• Hepatitis B and C viruses (HBV/HCV) are primary etiological agents for HCC.
• A comprehensive epidemiological analysis of HBV/HCV-associated HCC in the Arab world is currently lacking.

Purpose of the Study:

• To determine the burden of HBV/HCV-associated HCC deaths in the Arab world.
• To analyze trends in HCC mortality from 1990 to 2010 using the Global Burden of Disease (GBD) 2010 dataset.
• To compare HBV/HCV-associated HCC trends in the Arab world with global patterns.

Main Methods:

• Utilized the Global Burden of Disease (GBD) 2010 dataset for analysis.
• Examined data for 22 Arab countries, stratifying by age, sex, and economic status.
• Analyzed mortality trends from 1990 to 2010, comparing regional and global figures.

Main Results:

• Globally, 71% of HCC deaths in 2010 were HBV/HCV-associated (537,093 deaths).
• In the Arab world, 77% of HCC deaths in 2010 were HBV/HCV-linked (13,558 deaths).
• From 1990 to 2010, HBV-associated HCC deaths increased by 137% and HCV-associated by 216% in the Arab world, significantly exceeding global increases (62% and 73%, respectively).
• Age-standardized death rates rose in most Arab nations, with highest rates in Mauritania and Egypt.
• Higher mortality rates correlated with male gender and lower economic status.

Conclusions:

• The burden of HBV/HCV-associated HCC is increasing at a significantly faster rate in the Arab world compared to global trends.
• Urgent public health measures are imperative to mitigate this escalating trend.
• Addressing HBV/HCV-associated HCC is crucial to prevent further strain on regional healthcare systems.